Xie et al. investigated 16 biomarkers of systemic inflammation, comprising CRP, platelets, NC, LC, and albumin, in patients with NSCLC across all stages and treatment modalities [77]. The gene discussed is CRP; the disease is non-small cell lung carcinoma.